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Background: Intraoperative goal-directed fluid therapy (GDFT) is recommended in most perioperative
guidelines for intraoperative fluid management in patients undergoing elective colorectal surgery.
However, the evidence in elective colorectal surgery alone is not well established. The aim of this
meta-analysis was to compare the effects of GDFT with those of conventional fluid therapy on outcomes
after elective colorectal surgery.
Methods: A meta-analysis of RCTs examining the role of transoesophageal Doppler-guided GDFT
with conventional fluid therapy in adult patients undergoing elective colorectal surgery was per-
formed in accordance with PRISMA methodology. The primary outcome measure was overall
morbidity, and secondary outcome measures were length of hospital stay, time to return of gastro-
intestinal function, 30-day mortality, acute kidney injury, and surgical-site infection and anastomotic
leak rates.
Results: A total of 11 studies were included with a total of 1113 patients (556 GDFT, 557 conventional
fluid therapy). There was no significant difference in any clinical outcome measure studied between
GDFT and conventional fluid therapy, including overall morbidity (risk ratio (RR) 0⋅90, 95 per cent c.i.
0⋅75 to 1⋅08, P=0⋅27; I2 =47 per cent; 991 patients), 30-day mortality (RR 0⋅67, 0⋅23 to 1⋅92, P=0⋅45;
I2 = 0 per cent; 1039 patients) and length of hospital stay (mean difference 0⋅01 (95 per cent c.i. −0⋅92 to
0⋅94) days, P= 0⋅98; I2 =34 per cent; 1049 patients).
Conclusion: This meta-analysis does not support the perceived benefits of GDFT guided by trans-
oesophageal Doppler monitoring in the setting of elective colorectal surgery.
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Introduction
Intraoperative goal-directed fluid therapy (GDFT) using
measurements of stroke volume and cardiac output to
inform administration of a small volume of fluid (usually
200–250ml of a colloid, sometimes a crystalloid) to
optimize stroke volume has been used for over two decades.
A meta-analysis1 published in 2014 of 22 RCTs that
employed GDFT in a variety of elective and emergency
operations showed that the risk of developing compli-
cations after surgery was reduced by 23 per cent when
compared with conventional intraoperative fluid therapy.
However, a further meta-analysis2, which examined 23
RCTs including 2099 patients undergoing elective major
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abdominal surgery, suggested that GDFT may not be
of benefit in all patients, particularly those managed in
an enhanced recovery after surgery (ERAS)3,4 setting. A
recent RCT5 including 450 patients at low to moderate
risk undergoing major elective surgery demonstrated that
oesophageal Doppler-guided GDFT was associated with
a significant reduction in overall complications as well as
length of hospital stay.
Most guidelines for perioperative care in colorectal
surgery3,4,6,7 recommend that GDFT should be used for
patients undergoing colorectal surgery. Furthermore,
the UK National Institute for Health and Care Excel-
lence (NICE) has previously issued guidelines stating that
intraoperative GDFT with transoesophageal Doppler
monitoring should be used in ‘patients undergoing major
or high-risk surgery’8, with evidence supporting both a
clinical benefit and cost-saving based on the literature
available when the guideline was published in 2011.
Previous meta-analyses have been weakened by the
inclusion of patients undergoing both emergency and
elective surgery1,9 and a wide range of operations1,2,10,
and also by the fact that overall standards of perioperative
care have changed over the past two decades. Moreover,
the device used for monitoring stroke volume and cardiac
output varied across the individual RCTs2. Hydroxyethyl
starch (HES) was the colloid used frequently in the
GDFT arm, but recently there has been a call by the
European Medicines Agency for use of this fluid to be
suspended11 because of the increased incidence of acute
kidney injury (AKI) and the need for renal replacement
therapy12–14.
The aim of this meta-analysis of RCTs was to examine
the effect of GDFT using transoesophageal Doppler mon-
itoring compared with that of conventional intraoperative
fluid therapy on postoperative outcome, including AKI, in
patients undergoing elective major colorectal surgery.
Methods
The protocol for this meta-analysis was registered at the
outset with the PROSPERO database (www.crd.york.ac
.uk/prospero) (registration number CRD42018106818).
Search strategy
A search of the PubMed, MEDLINE, Google™ Scholar
and Cochrane Library databases was performed to identify
full-text studies evaluating the impact of intraoperative
GDFT on postoperative surgical outcomes in patients
undergoing elective colorectal surgery, published between
January 1995 and July 2018. The electronic search terms
used were [‘goal-directed fluid therapy’ OR ‘flow-directed
fluid therapy’] AND [‘surgery’ OR ‘intraoperative’] AND
[colon OR rectal OR colorectal]. No language restric-
tion was imposed on the search. Only studies including
adult patients undergoing elective colorectal surgery were
selected. The bibliographies of all studies that met the
inclusion criteria were hand-searched for any additional
suitable articles and relevant conference abstracts to
ensure study inclusion was as complete as possible. The
meta-analysis was conducted according to the PRISMA
statement15.
Selection of articles
Following the exclusion of initial studies on the basis of
article title and abstract by two independent researchers,
the remaining full-text articles were screened in detail
for inclusion. Studies were included if they examined
adult patients undergoing elective colorectal surgery who
were randomized to receive either GDFT administered
with transoesophageal Doppler monitoring or conven-
tional intraoperative fluid therapy, and if the study reported
at least one relevant postoperative outcome. Studies were
excluded if any patient had undergone non-colorectal
surgery, or if they included any emergency surgical pro-
cedures, employed any device other than the transoe-
sophageal Doppler for the conduct of GDFT, did not
include any relevant clinical outcome measures, or if both
groups received GDFT. Any studies in which inclusion cri-
teria were not clear were discussed by the authors, with the
final decision made by the senior author.
Data extraction
Study data were extracted from the included RCTs by one
author and checked by another. The primary outcome
measure examined was overall postoperative morbidity;
secondary outcome measures included 30-day mortality,
length of hospital stay (LOS), time to return of gastroin-
testinal function (flatus and stool), incidence of paralytic
ileus and AKI, and rates of surgical-site infection and
anastomotic leak. Data were also collated on patient
demographics (age, sex, ASA grade), surgical variables
(surgical procedure, number of laparoscopic procedures,
estimated blood loss) and intraoperative fluid administra-
tion (overall, maintenance and bolus fluid volumes, and
inotrope administration). Data were extracted on whether
the patient was managed using ERAS principles16,17 or
traditional perioperative care, and the method of admin-
istration of GDFT was noted. If data necessary for the
conduct of the meta-analysis were not available from the
© 2019 The Authors. www.bjsopen.com BJS Open 2019; 3: 606–616
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
608 K. E. Rollins, N. C. Mathias and D. N. Lobo
manuscript, the corresponding author was approached to
obtain this with the aim of ensuring data collection was
as complete as possible. If continuous data were reported
only as median (i.q.r.) values and authors did not provide
mean(s.d.) values, the technique described by Hozo et al.18
was used to estimate mean(s.d.) from median (i.q.r.) values.
This technique uses the median as the best estimate of
the mean, with the standard deviation calculated by the
following formula: (upper limit of i.q.r.− lower limit of
i.q.r.)/1⋅35.
Risk of bias was assessed using the Cochrane Collabora-
tion tool for assessing bias from Review Manager version
5.3 (RevMan; The Cochrane Collaboration, The Nordic
Cochrane Centre, Copenhagen, Denmark).
Statistical analysis
Data extracted from the included studies were entered into
the RevMan 5.3 software program. Dichotomous variables
were analysed using the Mantel–Haenszel random-effects
model and quoted as a risk ratio (RR) with 95 per cent con-
fidence intervals. Continuous variables were analysed using
the inverse-variance random-effects model and quoted as
a weighted mean difference (MD) with 95 per cent confi-
dence intervals.When theHozo technique18 had been used
to estimate mean(s.d.) data from studies included to inform
continuous data analysis, two separate meta-analyses were
conducted, one including the estimated data and one
excluding these data. Data were used to construct forest
plots, with P< 0⋅050 on two-tailed testing indicating a
statistically significant difference. Study heterogeneity and
inconsistency were assessed using the I2 statistic19, with 25
per cent or less representing low, 25–50 per cent moderate
and above 50 per cent high heterogeneity.
Results
Of 831 studies identified initially, 1120–30 were deemed
eligible for inclusion (Fig. 1). One published abstract31 was
identified that would have been suitable for inclusion, but
the data available from the text were insufficient to include
in the meta-analysis. Overall, the risk of bias of the studies
included was low and generally the quality of the studies
was medium to high (Table 1).
Demographics
The 11 RCTs in this meta-analysis20–30 included a total of
1113 adult patients who had undergone elective colorectal
surgery, of whom 556 were randomized to intraoperative
GDFT using transoesophageal Doppler monitoring and
557 to traditional intraoperative fluid management strate-
gies. In ten studies GDFT was administered as part of
an enhanced recovery programme, with just one study30
being conducted within a traditional care programme; thus
no analysis was conducted comparing patients managed
as part of these differing pathways. Data on laparoscopic
surgical approach only were provided by two studies26,27,
with no studies providing data from open-only approaches.
Baseline patient demographics are provided in Table S1
(supporting information), and fluid administered during
the perioperative period is detailed in Table S2 (supporting
information).
Overall morbidity
Nine studies21–26,28–30 including 487 patients managed
withGDFT and 504who had traditional fluidmanagement
reported overall morbidity rates (Fig. 2a). Overall morbid-
ity was not significantly different between these groups (RR
0⋅90, 95 per cent 0⋅75 to 1⋅08, P= 0⋅27; I2 = 47 per cent).
Length of hospital stay
Overall LOS was considered by ten studies20–26,28–30
included in the meta-analysis (1049 patients, 514 GDFT
and 535 traditional) (Fig. 2b). However, two studies20,26
included only median (i.q.r.) data and did not provide the
authors with mean(s.d.) data for the meta-analysis. These
data were estimated using the technique described byHozo
et al.18 and all data were included in the primary analysis
of LOS. A separate meta-analysis was performed for this
outcome excluding the estimated data.
In the first analysis, which included estimated data for
LOS, GDFT was not associated with a significant dif-
ference in the overall group (MD 0⋅01 (95 per cent c.i.
−0⋅92 to 0⋅94) days, P= 0⋅98; I2 = 34 per cent) (Fig. 2b).
In the second analysis, which excluded the estimated data,
GDFT resulted in no significant change in hospital length
of stay (MD −0⋅01 (−1⋅38 to 1⋅35) days, P= 0⋅99; I2 = 48
per cent).
Thirty-day mortality
Mortality rates were detailed in ten studies20,21,23–30,
including 519 patients in the GDFT group and 520 in the
traditional group (Fig. 2c). Overall there was no significant
difference in 30-day mortality between GDFT and control
patients (RR 0⋅67, 95 per cent c.i. 0⋅23 to 1⋅92, P= 0⋅45;
I2 = 0 per cent).
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Fig. 1 PRISMA diagram for the study
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GDFT, goal-directed fluid therapy.
Table 1 Risk of bias in the 11 included studies
Random
sequence
generation
(selection bias)
Allocation
concealment
(selection bias)
Blinding of
participants
and personnel
(performance bias)
Blinding of
outcome
assessment
(detection bias)
Blinding of
outcome data
(attrition bias)
Selective
reporting
(reporting bias)
Other
bias
Brandstrup et al.23 + + ? + + + +
Challand et al.25 ? ? ? + + + +
Conway et al.30 ? ? ? ? + + −
Gómez-Izquierdo et al.26 + + + + + + +
Noblett et al.28 ? ? + + + + −
Phan et al.21 + + − + + + +
Reisinger et al.20 + + − + + + ?
Senagore et al.27 + ? ? ? + + +
Srinivasa et al.22 + + − + + + +
Wakeling et al.29 + + + ? + + +
Zakhaleva et al.24 + + ? ? + + ?
+, Low risk of bias; ?, uncertain risk of bias; −, high risk of bias.
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Fig. 2 Forest plots of overall morbidity, length of hospital stay and 30-day mortality
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a Overall morbidity, b mean(s.d.) length of hospital stay (LOS) and c 30-day mortality in patients receiving goal-directed fluid therapy (GDFT) versus
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Fig. 3 Forest plots of surgical-site infection, anastomotic dehiscence and intra-abdominal collection
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a Surgical-site infection (SSI), b anastomotic dehiscence and c intra-abdominal collection in patients receiving goal-directed fluid therapy (GDFT) versus
controls. Risk ratios are shown with 95 per cent confidence intervals. Mantel–Haenszel random-effects models were used for meta-analysis.
Surgical-site infection
Five studies20–24 examined the incidence of surgical-site
infection: 217 patients managed with intraoperative
GDFT versus 237 controls (Fig. 3a). Use of GDFT
did not affect the rate of surgical-site infection signifi-
cantly (RR 0⋅61, 95 per cent c.i. 0⋅34 to 1⋅09, P= 0⋅10;
I2 = 0 per cent).
Anastomotic dehiscence
Seven studies20–24,26,29 included data on the rate of
anastomotic dehiscence: 345 patients managed with
intraoperative GDFT versus 365 control patients (Fig. 3b).
Intraoperative administration of GDFT did not affect the
incidence of anastomotic dehiscence (RR 0⋅90, 95 per cent
c.i. 0⋅43 to 1⋅90, P= 0⋅79; I2 = 2 per cent).
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Fig. 4 Forest plots of postoperative ileus, time to passage of flatus and time to passage of stool
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a Postoperative ileus, b mean(s.d.) time to passage of flatus and c mean(s.d.) time to passage of stool in patients receiving goal-directed fluid therapy
(GDFT) versus controls. a Risk ratios are shown with 95 per cent confidence intervals; a Mantel–Haenszel random-effects model was used for
meta-analysis. b,c Mean differences are shown with 95 per cent confidence intervals; inverse-variance random-effects models were used to perform the
meta-analyses.
Intra-abdominal collection
A total of four studies20,22–24 examined the relation-
ship between GDFT and conventional fluid therapy and
the rate of intra-abdominal collection (Fig. 3c). There
was no significant difference between the two groups
(RR 0⋅97, 95 per cent c.i. 0⋅33 to 2⋅86, P= 0⋅95; I2 = 0
per cent).
Postoperative ileus
Seven studies20–24,26,28 included data on the rate of post-
operative ileus: 332 patients managed with intraoperative
GDFT versus 353 control patients (Fig. 4a). The use of
GDFT did not affect the incidence of postoperative par-
alytic ileus significantly (RR 0⋅89, 95 per cent c.i. 0⋅49 to
1⋅60, P= 0⋅70; I2 = 36 per cent).
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Return of gastrointestinal function
Five studies examined time to return of gastrointestinal
function after surgery, in either the form of flatus24 or
both flatus and stool25,26,28,29. Two separate analyses were
performed for each outcome as in previous analyses.
For time to flatus in all studies, including those with
calculated data (Fig. 4b), there were 300 patients man-
aged with GDFT and 310 control patients in five
studies24–26,28,29. There was no significant difference
in the time to return of flatus between the two fluid
strategies (MD −0⋅11 (95 per cent c.i. −0⋅62 to 0⋅39) days,
P= 0⋅67; I2 = 76 per cent). Just two studies25,29 were left
when data calculated using the Hozo technique18 were
excluded, so a further meta-analysis was not attempted.
When time to stool was considered, 268 patients were
managed with GDFT and 270 with control intraopera-
tive fluid (Fig. 4c). There was no significant difference in
the overall group (MD −0⋅50 (95 per cent c.i. −1⋅42 to
0⋅43) days, P= 0⋅29; I2 = 82 per cent). When data for the
single study26 with estimated data were excluded, no differ-
ence in time to passage of stool was observed (MD −0⋅76
(−1⋅88 to 0⋅35) days, P= 0⋅18; I2 = 56 per cent).
Acute kidney injury
Four studies21,24,25,29 examined the relationship between
GDFT and conventional fluid therapy and the incidence
of AKI in 479 patients; there was no significant difference
between the two groups (RR 1⋅51, 95 per cent c.i. 0⋅85 to
2⋅66, P= 0⋅16; I2 = 0 per cent).
Discussion
This meta-analysis has demonstrated that in patients
undergoing elective colorectal surgery GDFT guided by
transoesophageal Doppler monitoring was not associated
with a significant difference in any postoperative clinical
outcome measure compared with conventional intraoper-
ative fluid therapy. There was an indication of difference
in terms of a reduced rate of surgical-site infection when
patients received GDFT, and increased rate of AKI, but
neither of these trends was statistically significant. Data
on the role of GDFT in the open versus the laparoscopic
approach for elective colorectal surgery were insufficient,
so the decision was taken not to perform a meta-analysis
for this variable. Further high-quality evidence is neces-
sary to assess the potential role of GDFT between surgical
approaches. Only one study30 examined the role of GDFT
as part of a traditional care pathway versus ten studies
within an ERAS pathway; hence no comparison could be
made between these settings.
These findings are more pronounced in the lack of ben-
efit for GDFT than found in a previous meta-analysis2
examining the role ofGDFT in elective abdominal surgery,
although that study2 did not limit the papers included
by the method of administration of GDFT. The previous
meta-analysis2 found that, overall, GDFT was associated
with a significant reduction in morbidity, LOS, duration of
stay in the ICU and time to passage of stool, with no signif-
icant difference observed in the incidence of postoperative
ileus, mortality or time to return of flatus.
An issue raised by other meta-analyses2,9,10 regarding the
comparison between GDFT and traditional fluid manage-
ment strategies is differences in fluid management strate-
gies over the past three decades. In the more historical
studies, large volumes tended to be infused in the tradi-
tionally managed group, whereas more contemporary fluid
management strategies observed in more recently pub-
lished studies tend to aim for zero balance and for the
patient to reach the anaesthetic room in a well hydrated
state. The U-shaped relationship between fluid volume
infused and perioperative morbidity that has been postu-
lated previously32 may suggest that in more modern fluid
management strategies33,34 the differences in clinical ben-
efit between GDFT and traditional intraoperative fluid
management may not be as pronounced if fluid overload
and deficits are avoided.
This study is the largest to examine the impact of GDFT
versus traditional fluid management strategies in elective
colorectal surgery. The only other previousmeta-analysis35
published on the topic has several methodological issues,
as it inadvertently included studies that were not RCTs,
despite this being the stated aim, and missed several key
studies on the topic. The present study included just
one method for the conduct of GDFT: transoesophageal
Doppler monitoring. This is the commonest device used
to perform GDFT in the UK, as well as in widespread use
internationally36, and is the method suggested by NICE
in the UK8. Evidence has suggested that transoesophageal
Doppler and other methods for GDFT such as lithium
dilution techniques37,38, calibrated pulse contour analysis39
and the pleth variability index40 are not interchangeable;
hence the decision was taken to make the study population
as homogeneous as possible.
Generally, the degree of heterogeneity within the analy-
ses conducted was low, with five analyses having low lev-
els of heterogeneity, four having moderate levels, and just
three having high levels of heterogeneity (those conducted
on time to passage of flatus and stool). This large degree of
concordance in study results, in addition to the relatively
high study quality, adds weight to the conclusions drawn.
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This meta-analysis has a few weaknesses inherent in its
design and conduct. The regimens for postoperative fluid
management were poorly documented in the included
studies. This may have impacted on postoperative out-
come, but cannot be accounted for. This study chose to
focus on just one technique for the conduct of GDFT,
transoesophageal Doppler monitoring, as this was felt to
improve the homogeneity of the meta-analysis. However,
this restricts the generalizability of the results to GDFT
conducted using other techniques. In addition, efforts
to obtain raw data for the continuous variables were not
successful. Therefore, the Hozo technique18 was used to
estimate mean(s.d.) data for two studies20,26 in the LOS
analysis, three studies26,28,29 in the time to return of flatus,
and one study26 in the time to return of stool. To negate
this potential weakness, an additional analysis, excluding
the estimated data, was planned at the outset of the conduct
of the meta-analysis. For the LOS analysis and time to
return of stool, excluding the estimated data, no difference
was observed in the outcome. However, as three of the
five studies required estimated data in the time to return
of flatus analysis, no further analysis was conducted due to
the poor strength of any conclusion drawn.
A similar meta-analysis35, including 11 RCTs, was pub-
lished in 2018 examining the role of GDFT in colorectal
surgery. However, two of these 11 studies were not RCTs:
one41 was a comparison between a series of patients
recruited to undergo GDFT and a historical series of
patients managed with traditional fluid management, and
the other42 was a matched cohort of patients who were
not randomized. In addition, three papers20–22, which
should have been included as they met the inclusion cri-
teria, were missed. They included a study30 of patients
undergoing ‘major bowel surgery’, which was excluded
from the present meta-analysis. All but one study used
transoesophageal Doppler-guided GDFT, with the sin-
gle remaining study43 including central venous oxygen
saturation-guided GDFT; however, this was excluded
from the present meta-analysis. The above-mentioned
methodological flaws in this paper35 weaken the strength
of the conclusions.
The nature of the fluid used for the bolus associated
GDFT was variable, with HES being the documented
fluid administered in seven studies20,21,23,25–27,30. How-
ever, there is a moratorium on the use of HES owing
to concerns of an increased risk of AKI requiring renal
replacement therapy12–14 as well as mortality12,14, based
on recent RCTs. The indication towards increasing rates
of AKI in patients receiving GDFT compared with those
having traditional fluid management could potentially be
related to the larger volume of HES infused in this group
and the inherent increased risks. Just four studies21,24,25,29
included data on AKI rates, with the nature of the bolus
fluid being variably reported in these. In one study25 HES
was administered for boluses, one21 gave a colloid although
the choice was ‘at the discretion of the anaesthetist’ and
included HES, gelatine or human albumin solution, one29
gave non-HES colloid, and one24 did not specify the type of
colloid given. If just those two studies21,25 clearly receiving
HES were analysed for AKI, the strength of the indication
increased; however, based on just two studies, this is far
from conclusive evidence. Future studies focusing on the
role of GDFT will not include HES as the bolus agent11,
and this may result in improved clinical outcomes.
This study has demonstrated no benefit for the rou-
tine use of transoesophageal Doppler-guided GDFT in
patients undergoing elective colorectal surgery, contrary
to NICE guidance8, which recommends that GDFT tech-
nology should be used ‘in patients undergoing major or
high-risk surgery’.
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